Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Nuclear medicine procedure guideline for sentinel lymph node localization].

Nuklearmedizin. Nuclear medicine·2024
Same author

Diagnostics and Therapy of Venous Thrombosis and Pulmonary Embolism. The revised AWMF S2k Guideline

VASA. Zeitschrift fur Gefasskrankheiten·2023
Same author

Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy.

Clinical and translational radiation oncology·2022
Same author

Reduced diffusion in white matter after radiotherapy with photons and protons.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2021
Same author

Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy.

Magma (New York, N.Y.)·2021
Same author

[What actually happens … in hybrid imaging?]

Der Radiologe·2020

Related Experiment Video

Updated: Jul 9, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

[FDG-PET/CT in oncology. German Guideline].

B J Krause1, T Beyer, A Bockisch

  • 1Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität, Ismaninger Strasse 22, 81675 Munich. bernd-joachim.krause@tum.de

Nuklearmedizin. Nuclear Medicine
|December 18, 2007
PubMed
Summary

This guideline details the use of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in oncology. It covers indications, acquisition, processing, and reporting for German clinical practice.

More Related Videos

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Experiment Videos

Last Updated: Jul 9, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
08:55

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Area of Science:

  • Nuclear Medicine
  • Radiology
  • Oncology

Background:

  • FDG-PET/CT integrates metabolic and morphologic imaging.
  • PET/CT has gained significant clinical acceptance in oncology over the last decade.

Purpose of the Study:

  • To provide a guideline for FDG-PET/CT examinations in oncologic patients within Germany.
  • To standardize indications, data acquisition, processing, and documentation.

Main Methods:

  • Discusses clinical and research applications of FDG-PET/CT.
  • Details protocols for CT scanning (low dose, contrast-enhanced) and PET emission imaging.
  • Specifies documentation, reporting, and image interpretation criteria.

Main Results:

  • Addresses quality control for FDG and PET/CT systems.
  • Outlines qualification requirements for personnel.
  • Covers legal aspects relevant to FDG-PET/CT in Germany.

Conclusions:

  • Establishes a comprehensive framework for FDG-PET/CT in German oncology.
  • Aims to improve the quality and consistency of oncologic imaging interpretation.
  • Ensures adherence to clinical, social, and legal standards.